An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study

Figure 1

(a) Duration of apatinib treatment in patients (days). (b) Kaplan–Meier plot for PFS.

(a)

(b)